Drug Testing

Does Kratom Show Up on a Drug Test?

Standard drug tests typically do not detect kratom or its active compounds, such as mitragynine and 7-hydroxymitragynine. However, specialized tests can identify kratom use, particularly if specifically requested by an employer or healthcare provider. Understanding the nuances of kratom detection is important for individuals concerned about drug screening.

Medically reviewed · Evidence-basedBy Benjamin Zohar, NCACIP · Reviewed by Brandon McNally, RNPublished · Updated · Last reviewed

Standard Drug Tests Typically Don't Detect Kratom

Most routine drug screenings, such as the common 5-panel or 10-panel urine tests, are designed to detect substances like opiates, cocaine, marijuana, amphetamines, and benzodiazepines. Kratom's primary active alkaloids, mitragynine and 7-hydroxymitragynine (7-OH), are chemically distinct from these commonly screened drugs. Therefore, a standard drug test is unlikely to flag kratom use.

This is a common misconception, leading some individuals to believe kratom use is undetectable. However, the absence of detection on a standard panel does not mean kratom use cannot be identified through other means.

Specialized Tests Can Detect Kratom

While not part of routine screenings, specific laboratory tests can identify kratom and its metabolites. These specialized tests are usually more expensive and are only performed if there is a particular reason to screen for kratom, such as in certain employment settings, pain management clinics, or forensic investigations. These tests typically look for mitragynine and 7-hydroxymitragynine.

Employers, probation officers, or healthcare providers may request these specialized tests if they have reason to suspect kratom use, especially in contexts where its use is prohibited or a concern. It's important to remember that testing capabilities are always evolving.

How Long Does Kratom Stay in Your System?

The detection window for kratom can vary significantly depending on the type of test used and individual factors. In urine, specialized tests may detect mitragynine and its metabolites for several days after last use. Hair follicle tests, similar to other substances, could potentially detect kratom for a much longer period, possibly up to 90 days, though specific research on kratom's hair detection window is less extensive.

Blood tests may detect kratom for a shorter duration, often within 24-48 hours. Saliva tests also have a relatively short detection window. These are general estimates, and individual metabolic rates play a crucial role in how quickly substances are eliminated from the body.

Factors Influencing Kratom Detection

Several individual and substance-related factors can influence how long kratom remains detectable in a person's system. These variables make it difficult to provide a precise universal detection timeline.

Key factors include:

  • Dosage and Frequency of Use: Higher doses and more frequent use generally lead to longer detection times.
  • Metabolism: Individual metabolic rates, influenced by genetics, age, and health, affect how quickly the body processes and eliminates substances.
  • Body Fat: Kratom alkaloids are fat-soluble, meaning they can be stored in fat cells, potentially extending detection times in individuals with higher body fat.
  • Hydration and Diet: While not a primary factor, overall health and hydration can subtly influence metabolic processes.
  • Liver and Kidney Function: Impaired organ function can slow down the elimination of substances from the body.

Transparency with Healthcare Providers

For individuals in recovery or those undergoing medical treatment, transparency with healthcare providers about all substances used, including kratom, is paramount. Withholding information can lead to misdiagnosis, adverse drug interactions, or inappropriate treatment plans. Healthcare professionals are there to help, not to judge.

If you are concerned about drug testing or your kratom use, seeking professional guidance is always recommended. Addiction treatment professionals can offer support, resources, and confidential advice tailored to your specific situation, helping you navigate these complex issues safely and effectively.

Frequently Asked Questions

Author

Benjamin Zohar, NCACIP

Nationally Certified Advanced Clinical Intervention Professional (NCACIP) · NAADAC Member · ISSUP Network Moderator

Benjamin Zohar is an addiction recovery professional, NAADAC member, and founder of Intervention New York (Intervention NY). A Nationally Certified Advanced Clinical Intervention Professional (NCACIP), he operates a statewide network of treatment navigation, placement, and crisis intervention services across New York, including the Hudson Valley Addiction Treatment Center, Long Island Addiction Treatment Resources, and Every1 Center. He specializes in clinical placement, structured family and executive interventions, and benefits navigation. As an ISSUP Network Moderator, he leads the Integrated Recovery & Intervention Education Network (IRIEN) and authors practical guides and peer-reviewed articles on emerging substance use threats. He also maintains active advocacy membership with the National Alliance on Mental Illness (NAMI).

Medically Reviewed By

Brandon McNally, RN

Registered Nurse (RN) · Medical Reviewer

Registered nurse who reviews clinical content for medical accuracy, ensuring information on 7-OH and kratom dependence, withdrawal, and treatment reflects current evidence-based standards.

References

  1. SAMHSA — Drug-Free Workplace Programs
  2. PubMed — kratom drug test detection
  3. MedlinePlus — Kratom
  4. NIDA — Kratom DrugFacts

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions about a medical condition or substance use. If you are experiencing a medical emergency, call 911.

Related Articles

Call 24/7: 1-800-662-4357